A rarely described use of neostigmine in a case of acute anticholinergic poisoning.
AP-HM, hôpitaux Sud, pharmacologie clinique CAP-TV, Marseille, France; Aix-Marseille université, Inserm, SESSTIM UMR 912, Marseille, France. Electronic address: romain.torrents@ap-hm.fr.
Romain
R
Torrents
AP-HM, hôpitaux Sud, pharmacologie clinique CAP-TV, Marseille, France.
Mathieu
M
Glaizal
AP-HM, hôpitaux Sud, pharmacologie clinique CAP-TV, Marseille, France.
Corinne
C
Schmitt
AP-HM, hôpitaux Sud, pharmacologie clinique CAP-TV, Marseille, France; Aix-Marseille université, Marseille, France.
Audrey
A
Boulamery
AP-HM, hôpitaux Sud, pharmacologie clinique CAP-TV, Marseille, France.
Luc
L
de Haro
AP-HM, hôpitaux Sud, pharmacologie clinique CAP-TV, Marseille, France; Aix-Marseille université, Inserm, SESSTIM UMR 912, Marseille, France.
Nicolas
N
Simon
D000208:Acute Disease; D000293:Adolescent; D018680:Cholinergic Antagonists / Q000506:poisoning*; D003988:Dibenzothiepins / Q000506:poisoning*; D005260:Female; D006801:Humans; D009388:Neostigmine / Q000627:therapeutic use*; D013406:Suicide, Attempted
D018680:Cholinergic Antagonists; D003988:Dibenzothiepins; D009388:Neostigmine; C013322:tropatepine